丹麦人乳头瘤病毒所致癌症负担及HPV疫苗接种的潜在效果
该研究基于文献中高危HPV人群流行率、HPV相关癌症中高危HPV型别分布、丹麦筛查细胞学样本数及NORDCAN癌症发病数据,估算丹麦每年由HPV引起的癌症例数。结果显示女性每年548例、男性234例,女性中疫苗可预防的癌症数是男性的两倍;若计入筛查预防的宫颈癌,女性HPV所致癌症负担为1300–2000例,男性为234例。结论认为计入筛查预防的宫颈癌后,HPV疫苗在女性中的癌症控制潜力远高于男性。
要点
- 丹麦横断面调查显示约五分之一女性及近三分之一男性高危HPV检测阳性。
- 每年诊断HPV所致癌症女性548例、男性234例,女性疫苗可预防癌症数为男性两倍。
- 计入筛查预防的宫颈癌后,女性HPV所致癌症负担为1300–2000例,男性为234例。
核心结论
- 计入筛查预防的宫颈癌后,HPV疫苗在女性中的癌症控制潜力远高于男性。
- HPV疫苗接种可减轻女性筛查负担及卫生资源负担。
研究设计与样本
- 研究从文献检索高危HPV人群流行率、HPV相关癌症中高危HPV流行率及基因型、宫颈筛查细胞学样本数等数据。
- 从丹麦国家健康服务登记处和丹麦国家患者登记处获取年度活检及锥切数据,从NORDCAN提取丹麦HPV相关癌症发病率。
- HPV所致癌症例数由HPV相关癌症例数乘以已知由高危HPV引起的比例计算得出。
主要发现
- 丹麦横断面调查中,约五分之一女性及近三分之一男性高危HPV检测阳性。
- 每年诊断HPV所致癌症女性548例、男性234例,女性疫苗可预防癌症数为男性两倍。
- 计入筛查预防的宫颈癌后,女性HPV所致癌症负担为1300–2000例,男性为234例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Denmark is one of the countries where Human papillomavirus (HPV)-vaccination at present includes only girls. However, the burden of HPV-related cancer in men is increasing, which would argue for gender-neutral vaccination. The aim of this study was to examine the burden of HPV-caused cancers in women and men, and to evaluate the potential of HPV-vaccination in cancer control. METHODS: Data were retrieved from the literature on population prevalence of high risk (HR) HPV, on HR HPV-prevalence and genotypes in HPV-related cancers, and on number of cytology samples in cervical screening. Data on annual biopsies and conisations were retrieved from the Danish National Health Service Register and the Danish National Patient Register. Incidences of HPV-related cancers in Denmark were extracted from NORDCAN. Number of HPV-caused cancers was calculated from number of HPV-related cancers and the proportion known to be caused by high-risk (HR) HPV. RESULTS: In cross-sectional surveys in Denmark, one fifth of women and almost one third of men were found to be positive for HR HPV. Per year, 548 HPV-caused cancer cases were diagnosed in women and 234 in men, and twice as many cancers in women as in men were preventable with HPV vaccination. However, including screening prevented cervical cancers, the burden of cancers caused by HPV-infection would be 1300-2000 in women as compared to 234 in men. CONCLUSION: Taking screening prevented cervical cancers into account, the cancer control potential of HPV-vaccination is considerably higher in women than in men. HPV-vaccination could reduce the burden of screening on women and on health care resources.
引用
- Skorstengaard M, Thamsborg LH, Lynge E, et al. Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination. Vaccine. 2017. PMID: 28923423. doi:10.1016/j.vaccine.2017.08.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。